Comparison between Clean Science IPO and Glenmark Life Sciences IPO.
Clean Science IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Glenmark Life Sciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Clean Science IPO is up to ₹1,546.62 Cr whereas the issue size of the Glenmark Life Sciences IPO is up to ₹1,513.60 Cr. The final issue price of Clean Science IPO is ₹900.00 per share and of Glenmark Life Sciences IPO is ₹720.00 per share.
| Clean Science IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹2 per share |
| Issue Price (Lower) | ₹880.00 per share | ₹695.00 per share |
| Issue Price (Upper) | ₹900.00 per share | ₹720.00 per share |
| Issue Price (Final) | ₹900.00 per share | ₹720.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 16 shares | 20 shares |
| Fresh Issue Size | 0 shares | 1,47,22,222 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,060.00 Cr |
| OFS Issue Size | 1,71,84,682 shares | 63,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,546.62 Cr | up to ₹453.60 Cr |
| Issue Size Total | 1,71,84,682 shares | 2,10,22,222 shares |
| Issue Size Total (Amount) | up to ₹1,546.62 Cr | up to ₹1,513.60 Cr |
Clean Science IPO opens on Jul 07, 2021, while Glenmark Life Sciences IPO opens on Jul 27, 2021. The closing date of Clean Science IPO and Glenmark Life Sciences IPO is Jul 09, 2021, and Jul 29, 2021, respectively.
| Clean Science IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | Jul 06, 2021 | Jul 26, 2021 |
| Issue Open | Jul 07, 2021 | Jul 27, 2021 |
| Issue Close | Jul 09, 2021 | Jul 29, 2021 |
| Basis Of Allotment (Tentative) | Jul 14, 2021 | Aug 03, 2021 |
| Initiation of Refunds (Tentative) | Jul 15, 2021 | Aug 04, 2021 |
| Credit of Share (Tentative) | Jul 16, 2021 | Aug 05, 2021 |
| Listing date (Tentative) | Jul 19, 2021 | Aug 06, 2021 |
| Anchor Lockin End date 1 | Aug 13, 2021 | Sep 02, 2021 |
| Anchor Lockin End date 2 | Oct 12, 2021 | Nov 01, 2021 |
Clean Science IPO P/E ratio is , as compared to Glenmark Life Sciences IPO P/E ratio of .
| Clean Science IPO | Glenmark Life Sciences IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 94.66 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 78.51 | 82.84 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹9559.71 Cr. | ₹8821.96 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Clean Science IPO Retail Individual Investors (RII) are offered 60,14,639 shares while in Glenmark Life Sciences IPO retail investors are offered 60,14,639 shares. Qualified Institutional Buyers (QIB) are offered 34,36,936 shares in Clean Science IPO and 42,04,450 shares in Glenmark Life Sciences IPO.
| Clean Science IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 51,55,404 shares | 63,06,660 shares |
| Market Maker Reservation | ||
| QIB | 34,36,936 shares | 42,04,450 shares |
| NII | 25,77,703 shares | 31,53,334 shares |
| RII | 60,14,639 shares | 73,57,778 shares |
| Employee | ||
| Others | ||
| Total | 1,71,84,682 shares | 2,10,22,222 shares |
Clean Science IPO subscribed 93.41x in total, whereas Glenmark Life Sciences IPO subscribed 44.17x.
| Clean Science IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| QIB (times) | 156.37x | 36.97x |
| NII (times) | 206.43x | 122.54x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 9.00x | 14.63x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 93.41x | 44.17x |
